Bristol-Myers Squibb Co DRC (BMY)

9,016.00 +45.00 (+0.50%)
Delayed Data ARS Disclaimer

BMY Financial Summary

Bristol-Myers Squibb Company reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was USD 341 million compared to USD 376 million a year ago. Revenue was USD 11,406 million compared to USD 11,985 million a year ago. Net income was USD 2,022 million compared to USD 2,372 million a year ago. Basic earnings per share from continuing operations was USD 0.96 compared to USD 1.08 a year ago. Diluted earnings per share from continuing operations was USD 0.95 compared to USD 1.07 a year ago.For the full year, sales was USD 1,488 million compared to USD 1,330 million a year ago. Revenue was USD 46,159 million compared to USD 46,385 million a year ago. Net income was USD 6,327 million compared to USD 6,994 million a year ago. Basic earnings per share from continuing operations was USD 2.97 compared to USD 3.15 a year ago. Diluted earnings per share from continuing operations was USD 2.95 compared to USD 3.12 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
BMY
Gross margin TTM 78.81%
Operating margin TTM 21.4%
Net Profit margin TTM 13.71%
Return on Investment TTM 10.29%
Total Revenue
Net Income
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Revenue 11,406 11,218 11,887 11,648
Gross Profit 8,886 8,951 9,312 9,229
Operating Income 1,767 2,427 2,822 2,850
Net Income 2,022 1,606 1,421 1,278
Clear All
0Selected
Please try another search
BMY
Quick Ratio MRQ 0.9
Current Ratio MRQ 1.25
LT Debt to Equity MRQ 113.19%
Total Debt to Equity MRQ 131.42%
Total Assets
Total Liabilities
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Assets 98,196 100,357 103,034
Total Liabilities 65,702 65,462 67,696 71,389
Total Equity 31,118 32,734 32,661 31,645
Clear All
0Selected
Please try another search
BMY
Cash Flow/Share TTM 5.89
Revenue/Share TTM 20.8
Operating Cash Flow 0.00%
Cash
Net Change in Cash
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Cash From Operating Activities 3,687 2,261 3,812
Cash From Investing Activities -2,081 -289 95
Cash From Financing Activities -3,246 -4,543 -3,520 -5,653
Net Change in Cash 1,368 -3,003 -1,619 -1,737
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.